These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

409 related items for PubMed ID: 16518441

  • 1. Oral transmucosal fentanyl citrate for cancer breakthrough pain: a review.
    Gordon DB.
    Oncol Nurs Forum; 2006 Nov 03; 33(2):257-64. PubMed ID: 16518441
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
    Mercadante S, Porzio G, Ferrera P, Fulfaro F, Aielli F, Verna L, Villari P, Ficorella C, Gebbia V, Riina S, Casuccio A, Mangione S.
    Eur J Pain; 2008 Nov 03; 12(8):1040-6. PubMed ID: 18353696
    [Abstract] [Full Text] [Related]

  • 4. Oral transmucosal fentanyl citrate (OTFC) for the treatment of breakthrough pain in cancer patients: a controlled dose titration study.
    Portenoy RK, Payne R, Coluzzi P, Raschko JW, Lyss A, Busch MA, Frigerio V, Ingham J, Loseth DB, Nordbrock E, Rhiner M.
    Pain; 1999 Feb 03; 79(2-3):303-12. PubMed ID: 10068176
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Danish pain specialists' rationales behind the choice of fentanyl transdermal patches and oral transmucosal systems--a delphi study.
    Jacobsen R, Møldrup C, Christrup L.
    Pain Med; 2009 Nov 03; 10(8):1442-51. PubMed ID: 19793344
    [Abstract] [Full Text] [Related]

  • 8. Single-dose pharmacokinetics of fentanyl sublingual spray and oral transmucosal fentanyl citrate in healthy volunteers: a randomized crossover study.
    Parikh N, Goskonda V, Chavan A, Dillaha L.
    Clin Ther; 2013 Mar 03; 35(3):236-43. PubMed ID: 23497761
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Fentanyl buccal tablet for breakthrough cancer pain: why titrate?
    Kleeberg UR, Filbet M, Zeppetella G.
    Pain Pract; 2011 Mar 03; 11(2):185-90. PubMed ID: 20807349
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Breakthrough pain frequency in cancer patients and the efficiency of oral transmucosal fentanyl citrate].
    Bilen A, Ali A, Baturay F, Altan A.
    Agri; 2010 Jul 03; 22(3):103-8. PubMed ID: 20865581
    [Abstract] [Full Text] [Related]

  • 15. A randomized clinical trial of oral transmucosal fentanyl citrate versus intravenous morphine sulfate for initial control of pain in children with extremity injuries.
    Mahar PJ, Rana JA, Kennedy CS, Christopher NC.
    Pediatr Emerg Care; 2007 Aug 03; 23(8):544-8. PubMed ID: 17726413
    [Abstract] [Full Text] [Related]

  • 16. Oral transmucosal fentanyl: new preparation. For breakthrough cancer pain when morphine fails.
    Prescrire Int; 2002 Aug 03; 11(60):106-7. PubMed ID: 12199262
    [Abstract] [Full Text] [Related]

  • 17. A comparison of intranasal fentanyl spray with oral transmucosal fentanyl citrate for the treatment of breakthrough cancer pain: an open-label, randomised, crossover trial.
    Mercadante S, Radbruch L, Davies A, Poulain P, Sitte T, Perkins P, Colberg T, Camba MA.
    Curr Med Res Opin; 2009 Nov 03; 25(11):2805-15. PubMed ID: 19792837
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of rapid-onset oral fentanyl formulations vs. oral morphine for cancer-related breakthrough pain: a meta-analysis of comparative trials.
    Jandhyala R, Fullarton JR, Bennett MI.
    J Pain Symptom Manage; 2013 Oct 03; 46(4):573-80. PubMed ID: 23380337
    [Abstract] [Full Text] [Related]

  • 19. The use of oral transmucosal fentanyl citrate during high-dose-rate gynecologic brachytherapy.
    Proud C.
    Clin J Oncol Nurs; 2007 Aug 03; 11(4):561-7. PubMed ID: 17723969
    [Abstract] [Full Text] [Related]

  • 20. A titration strategy is needed to manage breakthrough cancer pain effectively: observations from data pooled from three clinical trials.
    Hagen NA, Fisher K, Victorino C, Farrar JT.
    J Palliat Med; 2007 Feb 03; 10(1):47-55. PubMed ID: 17298253
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.